CARE CHL Hospitals | Indore, LIG Square - Endocrinology department logo

CARE CHL Hospitals | Indore, LIG Square - Endocrinology department

Research site
Location
CHL Hospitals 4th Floor, Next to Room 423 (Behind Physiotherapy Dept), Indore, Madhya Pradesh, India
Site insights

Top conditions

Type 2 Diabetes Mellitus (4 trials)

Diabetes Mellitus (3 trials)

Obesity (2 trials)

Diabetic Foot (1 trial)

Metabolic Syndrome (1 trial)

Top treatments

Tirzepatide
LY3298176
Saroglitazar
LY3437943
Retatrutide

Parent organization

This site is a part of CHL Hospitals

Data sourced from clinicaltrials.gov

Contact this site

Madhumati Pahuja

Verified by this site

Trials

3 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

A Phase 4, non-randomized, multicentre, open-label, single-arm study to evaluate the safety and efficacy of Saroglitazar 4 mg in patients with non-al...

Enrolling
Dyslipidemias
Obesity
Drug: Saroglitazar

Trial sponsors

Lilly logo

Lilly (3 trials)

Z

Zydus Pharmaceuticals (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems